106 related articles for article (PubMed ID: 28840658)
1. Experimental design and metabolic flux analysis tools to optimize industrially relevant Haemophilus influenzae type b growth medium.
da Silva MR; Andreia Freixo Portela C; Maria Ferreira Albani S; Rizzo de Paiva P; Massako Tanizaki M; Zangirolami TC
Biotechnol Prog; 2017 Nov; 33(6):1508-1519. PubMed ID: 28840658
[TBL] [Abstract][Full Text] [Related]
2. Characterization of polysaccharide production of haemophilus influenzae Type b and its relationship to bacterial cell growth.
Takagi M; Cabrera-Crespo J; Baruque-Ramos J; Zangirolami TC; Raw I; Tanizaki MM
Appl Biochem Biotechnol; 2003 Aug; 110(2):91-100. PubMed ID: 14515024
[TBL] [Abstract][Full Text] [Related]
3. Applying Central Composite Design and Response Surface Methodology to Optimize Growth and Biomass Production of Haemophilus influenzae Type b.
Momen SB; Siadat SD; Akbari N; Ranjbar B; Khajeh K
Jundishapur J Microbiol; 2016 Jun; 9(6):e25246. PubMed ID: 27630761
[TBL] [Abstract][Full Text] [Related]
4. [Specific characteristics of composition of synthetic nutrient media for cultivation of Hemophilus influenzae type b from the standpoint of bacterial metabolism].
Orlova OE; Iastrebova NE; Elkina SI
Zh Mikrobiol Epidemiol Immunobiol; 2001; (3):111-7. PubMed ID: 11550547
[TBL] [Abstract][Full Text] [Related]
5. [Dynamics of growth of Haemophilus influenzae serotype B and synthesis of capsular polysaccharide in the process of cultivation in a synthetic nutrient medium].
Orlova OE
Zh Mikrobiol Epidemiol Immunobiol; 2002; (2):75-7. PubMed ID: 12043160
[TBL] [Abstract][Full Text] [Related]
6. Recognition of flavin mononucleotide, Haemophilus influenzae type b and its capsular polysaccharide vaccines by antibodies specific to D-ribitol-5-phosphate.
Ravi G; Venkatesh YP
Glycoconj J; 2014 Nov; 31(8):573-85. PubMed ID: 25108762
[TBL] [Abstract][Full Text] [Related]
7. Evaluation and validation of a serum bactericidal antibody assay for Haemophilus influenzae type b and the threshold of protection.
Townsend K; Ladhani SN; Findlow H; Borrow R
Vaccine; 2014 Sep; 32(43):5650-6. PubMed ID: 25138290
[TBL] [Abstract][Full Text] [Related]
8. Process development of a New Haemophilus influenzae type b conjugate vaccine and the use of mathematical modeling to identify process optimization possibilities.
Hamidi A; Kreeftenberg H; V D Pol L; Ghimire S; V D Wielen LA; Ottens M
Biotechnol Prog; 2016 May; 32(3):568-80. PubMed ID: 26821825
[TBL] [Abstract][Full Text] [Related]
9. Response of MUTZ-3 dendritic cells to the different components of the Haemophilus influenzae type B conjugate vaccine: towards an in vitro assay for vaccine immunogenicity.
Hoefnagel MH; Vermeulen JP; Scheper RJ; Vandebriel RJ
Vaccine; 2011 Jul; 29(32):5114-21. PubMed ID: 21624423
[TBL] [Abstract][Full Text] [Related]
10. Development and scale-up of a fed-batch process for the production of capsular polysaccharide from Haemophilus influenzae.
Merritt J; Allard G; O'Toole L; Swartz R; Licari P
J Biotechnol; 2000 Aug; 81(2-3):189-97. PubMed ID: 10989178
[TBL] [Abstract][Full Text] [Related]
11. Haemophilus influenzae type b conjugate vaccines.
Kelly DF; Moxon ER; Pollard AJ
Immunology; 2004 Oct; 113(2):163-74. PubMed ID: 15379976
[TBL] [Abstract][Full Text] [Related]
12. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
13. Study of the chemical stability of the capsular polysaccharide produced by Haemophilus influenzae type b.
Cintra Fde O; Takagi M
Carbohydr Polym; 2015 Feb; 116():167-72. PubMed ID: 25458286
[TBL] [Abstract][Full Text] [Related]
14. Haemophilus influenzae type b infection in children in Pacific countries.
Carapetis JR; Russell FM; Mansoor O; Darcy A; Fakakovi T; Metai A; Potoi NT; Wilson N; Mulholland EK
Pac Health Dialog; 2004 Mar; 11(1):79-83. PubMed ID: 18181445
[TBL] [Abstract][Full Text] [Related]
15. [Influence of the aminopeptide concentration on the growth of Haemophilus influenzae, type b, and the synthesis of its capsular polysaccharide].
Orlova OE; Elkina SI; Iastrebova NE; Vaneeva NP; Sergeev VV; Kalina NG; Tokarskaia MM
Zh Mikrobiol Epidemiol Immunobiol; 2005; (3):92-5. PubMed ID: 16028527
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.
Mawas F; Bolgiano B; Rigsby P; Crane D; Belgrave D; Corbel MJ
Biologicals; 2007 Oct; 35(4):235-45. PubMed ID: 17337205
[TBL] [Abstract][Full Text] [Related]
17. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
18. Improvement in the purification process of the capsular polysaccharide from Haemophilus influenzae type b by using tangential ultrafiltration and diafiltration.
Albani SM; da Silva MR; Takagi M; Cabrera-Crespo J
Appl Biochem Biotechnol; 2012 Aug; 167(7):2068-75. PubMed ID: 22665219
[TBL] [Abstract][Full Text] [Related]
19. [Influence of nicotinamide adenine dinucleotide and hemin concentrations on the growth of Haemophilus influanzae type b and the synthesis of capsular polysaccharide].
Orlova OE; Elkina SI; Iastrebova NE; Vaneeva NP; Sergeev VV; Kalina NG; Tokarskaia MM
Zh Mikrobiol Epidemiol Immunobiol; 2005; (4):12-5. PubMed ID: 16146219
[TBL] [Abstract][Full Text] [Related]
20. Haemophilus influenzae type b vaccine failure in children is associated with inadequate production of high-quality antibody.
Lee YC; Kelly DF; Yu LM; Slack MP; Booy R; Heath PT; Siegrist CA; Moxon RE; Pollard AJ
Clin Infect Dis; 2008 Jan; 46(2):186-92. PubMed ID: 18171249
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
